Iyo FDA yakapa mobocertinib kukurumidza kubvumidzwa kune metastatic isiri-diki kenza yemapapu kenza neEGFR exon makumi maviri ekuisa shanduko

Gunyana 2021: Iyo FDA yakapa mvumo yakakurumidza kumobocertinib (Exkivity, Takeda Pharmaceuticals, Inc.) kuvarwere vakuru vane munharaunda yepamusoro kana metastatic isiri diki cell lung cancer (NSCLC) vane EGFR exon 20 insertio.

KRAS G12C, KRAS RGQ PCR kit, RAS GTPase, sotorasib

Sotorasib inogamuchira mvumo yekukurumidza kubva kune iyo FDA yeKRAS G12C mutant NSCLC

Nyamavhuvhu 2021: Iyo FDA yakapa mvumo yekukurumidza kuna sotorasib (Lumakras TM, Amgen, Inc.), iyo RAS GTPase mhuri inhibitor, yevakuru varwere vane KRAS G12C vakachinja munzvimbo yepamusoro kana metastatic isiri-diki kenza yemapapu kenza (NSCLC) w ..

ALK, B7461006, crizotinib, Lorbrena, lorlatinib, NCT03052608, Pfizer, Ventana ALK, Ventana Medical Systems

Lorlatinib yakagamuchirwa neDFA yekurapa metastatic ALK-positive NSCLC.

Nyamavhuvhu 2021: Lorlatinib (Lorbrena, Pfizer Inc.) akagamuchira mvumo yenguva dzose yeDAA kuvarwere vane metastatic isiri-diki kenza yemapapu kenza (NSCLC) vane mamota ane aplastic lymphoma kinase (ALK) -inotaridzika, sekugadzwa neiyo FDA-app ..

anaplastic lymphoma kinase, B7461006, CDx Assay, Zvokudya uye Drug Administration, Lorbrena, lorlatinib, NCT03052608, NSCLC, Pfizer, Ventana ALK, Ventana Medical Systems

Lorlatinib yakagamuchirwa neDFA yekurapa metastatic ALK-positive NSCLC

Nyamavhuvhu 2021: Lorlatinib (Lorbrena, Pfizer Inc.) akagamuchira mvumo yenguva dzose yeDAA kuvarwere vane metastatic isiri-diki kenza yemapapu kenza (NSCLC) vane mamota ane aplastic lymphoma kinase (ALK) -inotaridzika, sekugadzwa neiyo FDA-app ..

cemiplimab-rwlc, Egfr, FDA, Zvokudya uye Drug Administration, NCT03088540, NSCLC, PD-L1 kutaura

Cemiplimab-rwlc yakagamuchirwa neiyo FDA yeiyo isiri-diki kenza yemapapu kenza ine yakakwira PD-L1 expression

Nyamavhuvhu 2021: Iyo FDA yakabvumidza cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) yekurapa-mutsara wekutanga kurapwa kwevarwere vane epamberi isiri-diki maseru kenza yemapapu (NSCLC) (yemunharaunda yepamusoro avo vasiri mukwikwidzi wehururu ..

FDA, KRAS G12C, Lumakras, NSCLC, sotorasib

Iyo FDA yakabvumidza yekutanga kurapwa kwakanangwa kwekuchinja kwegomarara remapapu iyo yaimbofungidzirwa kuti isingarapike nemishonga.

Nyamavhuvhu 20, 2021: Munguva pfupi yapfuura muna Chivabvu, 2021 Lumakras (sotorasib) yakagamuchirwa neU.S.Food and Drug Administration semushonga wekutanga wevarwere vakuru vane gomarara risiri diki remapapu yemapapu avo vakamboita imwe chete yapfuura system ..

Cigaretti

Zvinopfuura gumi nezviviri muzana zvevachangobva kuongororwa varwere vegomarara remapapu vatsva vakaputa fodya - kudzidza kunoratidza

Chikunguru 7th 2021: Kusvuta fodya ndicho chinokonzera kukonzera kenza yemapapu, kuverengera pamusoro pe80% yevakafa vese kubva muchirwere. Vanhu vasingasvuti, zvakadaro, vanokonzererwa nekenza yemapapu. Zvinoenderana nedzidzo nyowani, arou ..

Kurwisa zvinodhaka mune isiri-diki kenza yemapapu kenza

Chii chaunofanira kuita pamusoro pekupokana nemushonga wekenza isiri-diki yemukenza yemapapu yakanangwa nemishonga, iwe unoda kuziva panoGomarara remapapu igomarara rine hurema hwakanyanya uye kufa muChina. Vanenge mamirioni 1.6 vanhu vanofa nechirwere ichi ehe ..

PD-1 uye PD-l1 kurapwa kwekenza yemapapu

Lung cancer immunotherapy, lung cancer immunotherapy, lung cancer PD-1 treatment, and lung cancer PD-L1 treatment are all you want to know. In the past two years, immune checkpoint inhibitors have undoubtedly been one of the most..

Brigatinib yeAlk-positive crizotinib inopesana isiri-diki kenza yemapapu kenza

Dong-Wan Kim nyanzvi kubva kuSeoul National University Hospital muSouth Korea vachapa mushumo wemuromo pamusangano wakakosha wemasastatic isiri-diki kenza yemapapu yemapapu paMusangano wegore wegumi nemaviri weAmerican Society yeOncolo ..